GSK Tightens Avandia Restrictions
Under orders from health regulators, GlaxoSmithKline PLC said Monday it had revised safety restrictions on the diabetes drug Avandia because of its links to heart attacks, in a move closely following...To view the full article, register now.
Already a subscriber? Click here to view full article